drugset / Trial / NCT05042635

Sequential Treatment of Psoriasis With Traditional Chinese and Western Medicine

NCT05042635

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to objectively and standardly evaluate the clinical efficacy and safety of sequential treatment of psoriasis with traditional Chinese and Western medicine through a multi-center, randomized, double-blind, placebo-controlled trial.

Timeline

Start
2021-10-01
Primary completion
2024-09-30
Completion
2024-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Chinese herbal medicine Traditional medicine (herbal / TCM) Oral
Background Ixekizumab Monoclonal antibody 80 mg Subcutaneous

Indications